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Abstract
Smallpox, caused by variola virus (VARV), is a devastating human disease that affected millions worldwide until the virus was
eradicated in the 1970 s. Subsequent cessation of vaccination has resulted in an immunologically naive human population
that would be at risk should VARV be used as an agent of bioterrorism. The development of antivirals and improved
vaccines to counter this threat would be facilitated by the development of animal models using authentic VARV. Towards
this end, cynomolgus macaques were identified as adequate hosts for VARV, developing ordinary or hemorrhagic smallpox
in a dose-dependent fashion. To further refine this model, we performed a serial sampling study on macaques exposed to
doses of VARV strain Harper calibrated to induce ordinary or hemorrhagic disease. Several key differences were noted
between these models. In the ordinary smallpox model, lymphoid and myeloid hyperplasias were consistently found
whereas lymphocytolysis and hematopoietic necrosis developed in hemorrhagic smallpox. Viral antigen accumulation, as
assessed immunohistochemically, was mild and transient in the ordinary smallpox model. In contrast, in the hemorrhagic
model antigen distribution was widespread and included tissues and cells not involved in the ordinary model. Hemorrhagic
smallpox developed only in the presence of secondary bacterial infections – an observation also commonly noted in
historical reports of human smallpox. Together, our results support the macaque model as an excellent surrogate for human
smallpox in terms of disease onset, acute disease course, and gross and histopathological lesions.
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Introduction
Smallpox is widely regarded as a scourge of epic proportions
whose history dates back to ca.1350 BCE when smallpox spread
from the Egyptians to the Hittites in Syria [1]. It has been
recorded throughout human history with the last naturally
occurring cases being reported in 1975 in the Indian subcontinent
and in 1977 in the Horn of Africa [1]. The eradication of human
smallpox, conducted under the auspices of the World Health
Organization (WHO), involved a worldwide campaign of ring
vaccination, and vigorous tracking of individual smallpox cases
[2,3,4,5]. The success of the campaign was due, in part, to the lack
of animal reservoirs that could reintroduce the virus into the
human population. Following eradication, the remaining stocks of
VARV were either consolidated into two maximum-containment
facilities designated as the WHO Collaborating Centers for
Smallpox and Other Poxvirus Infections, or destroyed [6].
Beginning in 1980, the vaccination program for smallpox was
dismantled, resulting in the world’s population now being largely
susceptible to this disease. Unfortunately, following eradication,
the USSR developed VARV as a strategic bioweapon [7,8], and
concerns remain that VARV has the potential to be used as an
agent of bioterrorism. For this reason, improved countermeasures
against smallpox including new vaccines and antiviral drugs are
urgently needed.
Development of countermeasures for biothreat agents requires
demonstration of efficacy in an animal model infected with the
authentic agent resulting in a progression of events recapitulating
the human disease process [9]. In humans, the clinical manifes-
tations of naturally acquired smallpox begin after an incubation
period of 7–17 days following exposure. The initial symptoms of
disease are indistinguishable from many other virus infections and
may include backache, headache, vomiting, prostration and fever
that can spike upwards of 39uC. The febrile phase may continue
for 3–4 days before the appearance of a centrifugally distributed,
systemic rash. The rash progresses from a macular to papular
stage, after which vesicles evolve on day 4 and pustules on day 7
post fever onset. The classical form of smallpox, caused by variola
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1) ordinary smallpox, occurred in 90% of cases (case-fatality rate
correlated with the severity of rash and ranged from 10–75%); 2)
modified smallpox (5% of the cases) was less severe in clinical
presentation (case-fatality rate ,10%) and frequently occurred in
previously vaccinated individuals; 3) Variola sine eruption
presented as a fever without rash and serological evidence was
required to confirm infection was due to VARV; 4) flat smallpox
occurred in 5% of cases and was distinguished by a more slowly
developing rash and generalized infection (case-fatality rate
$80%); and 5) hemorrhagic smallpox (1% of cases), characterized
by hemorrhages into the skin and mucous membranes and
uniform lethality [10].
Even though the clinical presentation and pathology of human
smallpox have been previously documented [11,12,13,14], much
of smallpox pathogenesis remains to be characterized. The
development of an animal model to recapitulate this disease
progression has been hindered by the host range of natural VARV
which is restricted to humans. Nevertheless, initial studies to
explore the potential of VARV infection in cynomolgus macaques
yielded promising results, with animals developing fulminant and
lethal infection with end-stage lesions reminiscent of human
disease. Studies by Jahrling et al identified a dose-dependent
disease course in which high dose inoculation resulted in
hemorrhagic diathesis and 10-fold lower doses produced ordinary
smallpox [15]. By their nature, those preliminary studies did not
include temporal pathology analysis. Thus, the current serial
pathogenesis study was performed in cynomolgus macaques that
were inoculated intravenously (iv) with either 10
8 plaque forming
units (pfu) or 10
9 pfu doses of VARV designed to produce
ordinary-like or hemorrhagic-like smallpox, respectively. Animals
were monitored for clinical signs of disease including lesion counts,
temperature, body weight, serum chemistries, and hematology
analysis. Additionally, samples acquired at necropsy were
evaluated histologically, immunohistochemically, and ultrastruc-
turally. Quantitative real-time polymerase chain reactions (qrt-
PCRs) and enzyme-linked immunosorbent assays (ELISAs) were
used to measure viremia and immune mediators, respectively.
These studies significantly advance our understanding of VARV
pathogenesis in primates and increase confidence in the VARV
cynomolgus monkey model for facilitating development of
antiviral drugs, improved countermeasures, and suggesting
potential targets for therapeutic intervention in humans.
Results
Comparative Pathology of VARV Infection
Gross Necropsy Findings. 10
8 pfu Group.
Eighteen vaccinia virus-naı ¨ve cynomolgus macaques (Macaca
fascicularis) were inoculated intravenously (iv) with 10
8 pfu VARV
Harper strain and necropsied on days 1, 3, 5, 7, 9 and 11 post
infection (n=3/time point). The major postmortem findings are
listed in Table 1. Significant lesions first became apparent on day 3
and were limited to peripheral and visceral lymphadenopathy and
prominent splenic lymphoid follicles in one animal only.
Peripheral lymphadenopathy developed in all animals by day 5,
persisted throughout the study, and increased in severity as the
disease progressed. Exanthema and enanthema first became
apparent on day 5 and consisted of numerous macules and
papules on the legs, arms, face, lips, and tongue of all animals.
Mean cutaneous lesion counts, in excess of 1,000, peaked between
days 7 and 8 and distribution expanded to include the palmar and
plantar surfaces, tail, scrotum, and prepuce. Oral mucosal lesions
peaked at day 5 and declined to a single umbilicated pustule on the
tongue of one animal by day 11. Additional findings included
multifocal testicular hemorrhage and splenic congestion.
Gross Necropsy Findings. 10
9 pfu Group.
Nine vaccinia virus-naı ¨ve cynomolgus macaques (Macaca
fascicularis) were inoculated intravenously with 10
9 pfu VARV
Harper strain and scheduled for necropsy on days 1, 3, and 4 post
infection (n=3/time point). The time points chosen for this group
were based on the accelerated disease course previously observed
[15]. All of the day 1 and day 3 animals were euthanized
according to schedule. The day 4 animals developed a secondary
bacterial infection and were found dead on days 2 (n=1) and 3
(n=2). The major postmortem findings are listed in Table 2. In
contrast to the 10
8 pfu group, poxviral papules and pustules were
not found, and cutaneous lesions were limited to a petechial rash
in 2/3 of the animals euthanized on day 3. One of these animals
also had a single focus of colonic mucosal hemorrhage. Among the
animals found dead, 2 had multifocal hemorrhages within the
urinary bladder mucosa, and of those, 1 had additional
hemorrhage in the cecal mucosa and irides. The third animal in
this group had focal hemorrhage within the peripancreatic
mesentery. Hepatic congestion was present in all of the animals
found dead, and splenic congestion was found in two of the
animals euthanized on day 3. Peripheral and visceral lymphade-
nopathy was found in all of the animals euthanized on day 3 and a
single animal found dead.
Histopathology. 10
8 pfu Group.
Epitheliocentric lesions were commonly found in haired skin
and oronasal mucosa. Cutaneous lesions became apparent
histologically at day 3, and consisted of mild epithelial cell swelling
and hyperplasia which progressed to ballooning degeneration and
necrosis with typical intraepidermal vesicles and eosinophilic
intracytoplasmic inclusion bodies (ICIB) by day 5 (Figure 1). At
days 7 and 9, epidermal and follicular pustules were apparent, and
by day 11, epidermal crusts and lymphoplasmacytic dermatitis
predominated. Mucosal lesions were similar and commonly
involved nasal, tonsillar and glossal epithelium. Despite the
relative lack of gross oral mucosal lesions at days 9 and 11,
histopathologic lesions were readily apparent. Immunohistochem-
ical (IHC) staining for poxviral antigen was commonly found in
cutaneous and mucosal epithelial cells surrounding and within the
lesions.
Splenic changes were common and included mild congestion
and red pulp neutrophilia on day 1 and minimal to mild lymphoid
hyperplasia on days 5 through 11. The splenic cords and sinusoids
were expanded by large numbers of plasma cells and macrophages
by days 9 and 11. Immunohistochemistry revealed distinct
poxviral antigen staining within the marginal zone of primary
follicles, as well as occasional single cells within the sinusoids, on
day 1 (Figure 2). On day 3, marginal zone staining persisted and
additional staining was found centrally in early germinal centers
Table 1. Major Gross Pathology Findings – 10
8 pfu group.
Lesion Day 1 Day 3 Day 5 Day 7 Day 9 Day 11
Lymphadenopathy 0 1 3 3 3 3
Exanthema 0 0 3 3 3 3
Enanthema 0 0 3 3 1 1
Splenic Congestion 1 1 2 0 1 1
Testicular Hemorrhage 0 0 2 1 0 0
Values indicate the number of animals affected per group of 3.
doi:10.1371/journal.pone.0024832.t001
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cytoplasm of large pleomorphic to stellate cells with vesicular
nuclei and abundant cytoplasm. No viral antigen staining was
found on days 5–11.
Mandibular, mediastinal, axillary, inguinal, and mesenteric
lymph nodes were examined. Lymphoid hyperplasia became
apparent at day 5 and was most developed by day 11 (Figure 3).
Marked subcapsular and medullary sinus histiocytosis, and mild
hemorrhage, edema, and neutrophilia were present throughout
the study. As in the spleen, by days 9 and 11 the medullary cords
were expanded by large numbers of plasma cells. No positively
stained cells were identified by IHC at any time point (Figure 3).
Additional histopathologic lesions were found in the testes, bone
marrow, and conjunctiva. Testicular degeneration, occasionally
accompanied by multiple large foci of lymphoplasmacytic and
histiocytic inflammation, first appeared at day 5 and persisted
through day 11 (Figure 4). Distinct viral antigen staining was found
in the interstitial cells surrounding degenerate seminiferous tubules
(Figure 4). Marked myeloid hyperplasia also first appeared on day
5 and persisted through day 11; no viral antigen staining was
found within the bone marrow at any time point (Figure 5). One
animal in the day 5 group had a minimal neutrophilic
conjunctivitis that exhibited positive viral antigen staining. Viral
antigen staining by group and tissue type is shown in Figure 6.
Histopathology. 10
9 pfu Group.
Despite the lack of gross exanthema or enanthema, typical
epithelial hyperplasia, ballooning degeneration and ICIB, as seen
in the early stages of the 10
8 pfu group, were evident histologically
at all time points. In the animals euthanized on days 1 and 3,
lesions were present in 1/3 and 2/3 of the animals, respectively,
and were confined to the oronasal mucosa. Among the animals
that were found dead, all exhibited oronasal, cutaneous, and
esophageal lesions.
Splenic changes in the animals euthanized on days 1 and 3
resembled those seen in the 10
8 pfu group, including marginal
zone and early germinal center viral antigen staining; however,
antigen staining of individual cells within the sinusoids was more
common. Splenic changes in the animals that died prematurely
drastically differed from all other animals and included marked
lymphocytolysis and lymphoid depletion, congestion, neutrophilic
inflammation, and small colonies of bacterial cocci (Figure 2D).
Viral antigen staining in this group was more robust and
distribution also included the periarteriolar lymphoid sheaths
(Figure 2E). Ultrastructurally, virions and fibrin were readily
apparent (Figure 2F), and poxviral particles were found in the
cytoplasm of cells morphologically consistent with macrophages
(Figure S1).
Mandibular, mediastinal, axillary, inguinal, and mesenteric
lymph nodes were examined, and similar to the 10
8 pfu group,
lymphoid hyperplasia, sinus histiocytosis, and mild hemorrhage,
edema, and neutrophilia were present in the animals euthanized
on days 1 and 3. Viral antigen staining was limited to scattered
macrophages in three lymph nodes. Lymph node changes in the
animals that were found dead included marked follicular
lymphocytolysis and depletion (Figure 3) and mild to moderate
subcapsular sinus hemorrhage. Viral antigen staining was robust
and, similar to the spleen, localized to the mantle zone (Figure 3)
and macrophages throughout the subcapsular and medullary
sinuses. In some nodes, large amounts of antigen were found
within depleted germinal centers.
Additional histopathologic lesions were found in the intestinal
tract, urinary bladder, bone marrow, gonads, and adrenal glands.
Hemorrhage was a significant finding only in the animals that died
prematurely and was found in the colon (2/3), small intestine (2/
3), urinary bladder (2/3), and iris (1/3). Bone marrow changes
were not apparent in the animals euthanized on day 1, and only
mild myeloid hyperplasia was seen in 2/3 of the animals
euthanized on day 3; no viral antigen staining was seen in either
group. In contrast, all of the animals that were found dead
exhibited marked hematopoietic necrosis and multifocal hemor-
rhage with widespread cytoplasmic antigen staining (Figure 5).
Ultrastructural findings included hemorrhage, fibrin, and viral
particles; Figure S2 demonstrates immature virions within the
cytoplasm of both an apoptotic granulocyte and an adjacent lysed
cell. Gonadal changes in the animals euthanized on days 1 and 3
were limited to mild testicular degeneration. As in the 10
8 pfu
group, viral antigen staining was localized to interstitial cells
adjacent to degenerate tubules. The only female animals in this
study were the 3 that died prematurely and no ovarian lesions
were found. However, in all 3 animals viral antigen staining was
distinct and localized to the thecal cell layer of secondary and
tertiary follicles (Figure 4). Mild adrenocortical epithelial degen-
eration with eosinophilic ICIB was also seen in the animals that
died prematurely, and robust viral antigen staining was found
primarily in the zona fasciculata. Positive viral antigen staining was
also seen in many otherwise normal tissues, as is detailed in
Figure 6. Epithelial cells, histiocytes, and vascular pericytes were
the most commonly affected cell types; less commonly, endothelial
cell staining was noted. The kinetics of viral antigen distribution
are discussed below. All three of the animals that died prematurely
had histologic evidence of a secondary bacterial infection including
acute interstitial pneumonia and/or bacterial hepatitis. Bacteria
were evident in several organs including the lung, liver, spleen, and
kidney. Gram stain revealed primarily monomorphic colonies of
Table 2. Major Gross Pathology Findings – 10
9 pfu group.
Lesion Day 1 (euthanized) Day 3 (euthanized) Day 4* (Premature deaths)
Petechial Rash 0 2 0
Intestinal Hemorrhage 0 1 1
Other Hemorrhage 0 0 3
Splenic Congestion 0 2 1
Hepatic Congestion 0 0 3
Lymphadenopathy 0 3 1
Values indicate the number of animals affected per group of 3.
*animals scheduled for euthanasia on day 4 succumbed on days 2 or 3.
doi:10.1371/journal.pone.0024832.t002
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negative coccobacilli were also seen. The necessary fixation of
tissues for removal of samples from biocontainment, unfortunately,
made retrospective bacterial cultures and/or PCR impossible.
Additionally, because the infections were not clinically apparent,
the need for blood or organ cultures was not recognized until after
the postmortem exams were complete.
Clinical Pathology. Daily hematologic evaluation included
total white and red blood cell counts, platelet count, total
hemoglobin (Hb), hematocrit (HCT), mean corpuscular volume
(MCV), mean corpuscular hemoglobin (MCH), and mean
corpuscular hemoglobin concentration (MCHC). Hemogram
findings were similar in the both the 10
8 pfu and 10
9 pfu groups
(Figure S3). Normocytic, normochromic anemia developed at day
3 and progressively worsened to a final mean HCT of 18% on day
11 (227% change from day 1). Leukocytosis developed in both
groups, but occurred earlier in the 10
9 pfu group than the 10
8 pfu
group (day 2 vs day 5). In the 10
8 pfu group, total WBC counts
peaked at day 6–7 and fell to the upper end of the reference range
by day 11. Platelet counts remained within reference range
throughout the disease course, indicating that thrombocytopenia
did not play a role in the development of hemorrhage in the three
10
9 pfu dose animals that died prematurely.
Daily serum chemistry evaluation included albumin, total
protein, alkaline phosphatase, alanine aminotransferase, aspartate
aminotransferase, total bilirubin, blood urea nitrogen, creatinine,
cholesterol, glucose, calcium, and amylase. Mild hypoalbumin-
emia (2–2.5 mg/dL) was the only significant finding and was
similar for both the 10
8 pfu and 10
9 pfu dose groups (Figure S4).
This change in the face of normal total protein and renal and
hepatic markers, suggests acute inflammation, increased vascular
permeability, or both. Serum globulin concentrations were not
measured.
Variola virus dissemination kinetics
Quantitative rt-PCR and IHC staining were performed to
quantify VARV spread in vivo. In previous studies viral replication
was assessed in all tissues collected by both PCR and plaque assay.
Comparison of pfu to genomes showed on average a 200:1
genome to plaque ratio with no indication of inhibition of PCR in
any of the tissues tested. Mean tissue genome concentrations for
spleen, liver, bone marrow, lymph node, lung, heart, kidney, testis,
brain, and blood are shown for the 10
8 pfu and 10
9 pfu dose
groups in Figures S5 and S6, respectively. In the 10
8 pfu dose
group, a .1000-fold increase in circulating VARV genome titer
occurred over the disease course, and the initial appearance of
gross cutaneous lesions correlated with a genome concentration of
approximately 10
5/ml blood (Figure S5). Consistent with iv
inoculation and the sinusoidal structure of the spleen and liver,
titers in these organs peaked on day 1 (.10
8/g) and progressively
declined to ,10
6/g by day 11. The highest titers, in excess of
10
9genomes/g, occurred in bone marrow on days 3 and 5 and in
testis on day 5. Indeed, testis had the highest genome
concentrations of all organs examined and reached a peak titer
of 5.6610
9 genomes/g on day 5 post-exposure. Lymph node titers
remained stable at 10
6–10
7/g throughout the course of the study.
Genome titers in the 10
9 pfu group were greater than those in
the 10
8 pfu group (Figures S5 & S6). Among the animals that
received the 10
9 pfu dose, viral genome titers in all tissues
examined were greatest in the animals that died prematurely. The
highest concentrations were observed in the spleen and exceeded
10
13/g tissue. Similar to the 10
8 pfu group, liver, bone marrow
and spleen were primary targets of infection.
Consistent with the qrt-PCR findings, VARV antigen was
detected immunohistochemically as early as day 1 post-exposure
in the spleen and liver in both groups (Figure 6). In the 10
8 pfu
group, at 3 days post-infection antigen persisted in the spleen and
liver and also became apparent in haired skin, oral and laryngeal
mucosa, and tonsil. By mid-infection (days 5–7), splenic and
hepatic involvement was largely cleared, epidermal and mucosal
epithelial involvement persisted, and the sex organs (prostate,
Figure 1. Progression of cutaneous lesions in the 10
8 pfu
group. Day 3: Focal area of mild epidermal hyperplasia and
keratinocyte swelling. Day 5: Marked epidermal hyperplasia with
ballooning degeneration and early vesicle formation (*). Day 7:
Intraepidermal pustule and early crust formation; dermal inflammation
is primarily neutrophilic. Day 11: Resolution of epidermal hyperplasia
and replacement by large serocellular crust; dermal inflammation is
primarily lymphohistiocytic, H&E 10X; mag bars=50 um.
doi:10.1371/journal.pone.0024832.g001
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8 pfu group. A: Day 1, Positive staining (brown) is localized to the marginal
zone of primary follicles (*) and scattered individual cells within the sinusoids (arrows). Additional positive staining on Day 3 within the marginal zone
of primary follicles (B) and within early germinal centers (C), anti-vaccinia IHC; 20X; mag bars=50 um. D-F: Splenic changes in the 10
9 pfu premature
death group. D: Diffuse red pulp hemorrhage and congestion, and marked white pulp lymphocytolysis and lymphoid depletion, H&E 20X; mag
bar=50 um. E: Widespread poxviral IHC staining (brown) is localized to the periarteriolar lymphoid sheaths (*), individual cells within the sinusoids
(arrows), and follicular marginal zones (not shown), anti-vaccinia IHC; 20X; mag bar=50 um. F: Ultrastructural appearance of mature virions, fibrin,
and a degenerate cell, TEM; 40000X; mag bar=500 nm.
doi:10.1371/journal.pone.0024832.g002
Figure 3. Lymph node changes in the 10
8 pfu (top) and 10
9 pfu (bottom) dose groups. 10
8 pfu dose, Day 11: Marked lymphoid hyperplasia
with large numbers of secondary follicles containing well developed germinal centers (*), H&E 5X; mag bar=100 um. Poxviral immunohistochemistry
(right) is negative, anti-vaccinia IHC; 5X; mag bar=100 um. 10
9 pfu dose, premature death group, Day 2: Follicular depletion and lymphocytolysis
with abundant apoptotic debris, H&E 20X; mag bar=50 um. Poxviral IHC staining (brown) is localized to the mantle zone and scattered individual
cells within the paracortex and sinuses, anti-vaccinia IHC; 20X; mag bar=50 um.
doi:10.1371/journal.pone.0024832.g003
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8 pfu dose), Day 5: Areas of testicular
(seminiferous tubule) degeneration (*) adjacent to normal seminiferous tubules (arrows), H&E 10X; mag bar=50 um. Poxviral IHC staining (brown) is
localized to the interstitium surrounding degenerate tubules; normal areas are negative, anti-vaccinia IHC; 10X; mag bar=50 um. Females (10
9 pfu),
Day 2: H&E shows normal ovary with primordial, primary, secondary, and tertiary follicles, and remnant corpus luteum, H&E 5X; mag bar=100 um.
Poxviral IHC staining is primarily localized to the thecal cell layer of secondary and tertiary follicles, anti-vaccinia IHC; 5X; mag bar=100 um.
doi:10.1371/journal.pone.0024832.g004
Figure 5. Bone marrow changes in the 10
8 pfu (top) and 10
9 pfu (bottom) dose groups. 10
8 pfu dose, Day 9: Marked myeloid hyperplasia,
H&E 20X; mag bar=50 um. No poxviral IHC staining, anti-vaccinia IHC; 20X; mag bar=50 um. 10
9 pfu premature death group, Day 2: Diffuse
hematopoietic necrosis and multifocal hemorrhage, H&E 20X; mag bar=50 um. Widespread poxviral staining (brown), anti-vaccinia IHC; 20X; mag
bar=50 um.
doi:10.1371/journal.pone.0024832.g005
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9–11), VARV antigen was predominantly detected in the skin and
oronasal mucosa.
In the 10
9 pfu group, antigen distribution varied by group.
Findings in the animals euthanized on days 1 and 3 were similar to
those seen in the 10
8 pfu group except that distribution on day 3
extended beyond the spleen, liver, skin, and mucosa to include
urogenital organs, occasional lymph nodes, colon, and adrenal
gland. In contrast, spread of virus in the animals that died
prematurely was explosive with robust staining found in most
tissues regardless of whether they died on day 2 or 3 post exposure.
As noted above, epithelial cells, histiocytes, and vascular pericytes
were the most commonly infected cell types. Skeletal muscle
staining at the injection site was seen in several animals.
Discussion
We previously described a cynomolgus macaque model for
smallpox. In the present study, this model was refined with a focus
on the temporal effects of VARV on the host. Special emphasis
was placed on the virological, immunological, and pathological
changes over time in both ordinary and hemorrhagic models of
smallpox. Understanding the progression of disease will help to
identify potential time points for therapeutic intervention, as well
as fulfill requirements of the US Food and Drug Administration
(FDA) Animal Efficacy Rule established to facilitate the accep-
tance of animal models for drug efficacy testing.
In the present study, two clinical types of variola major disease
were modeled: ordinary and hemorrhagic. Similar to human
Figure 6. Cumulative poxviral immunohistochemistry scores by tissue type in the 10
8 pfu and 10
9 pfu dose groups. IHC stains were
subjectively scored on a 0–4 scale (0 = none; 1=minimal; 2=mild; 3=moderate; 4=marked). For each tissue type, IHC scores for all 3 animals from
the same dose and necropsy day group were summed. If, for an individual animal, more than one slide of the same tissue type was examined and
scored, the average score for that tissue type was used in the summation.
doi:10.1371/journal.pone.0024832.g006
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time to death, and overall severity of disease. Interestingly,
inoculation dose was not the sole determinant of disease
manifestation, as not all animals in the 10
9 pfu group developed
hemorrhagic smallpox. This was unexpected since our previous
studies showed a strong correlation between high inoculation dose
and the occurrence of hemorrhagic disease [15]. In this study,
hemorrhagic disease developed only in animals that also acquired
a secondary systemic bacterial infection, suggesting the bacterial
infection potentiated the viral infection. This was most strikingly
reflected in the more widespread and robust viral antigen staining
in the animals that developed hemorrhagic disease. While initially
alarming, this observation corroborates the fidelity of the primate
model in recapitulating the lethal form of human smallpox.
Historically, systemic bacterial infections were especially common
in cases of hemorrhagic smallpox and much speculation centered
on the role of these organisms in smallpox pathogenesis [12]. This
finding has also been observed in experimental monkeypox virus
infections in cynomolgus macaques where despite receiving
equivalent doses, hemorrhagic disease only occurred when a
concurrent secondary bacterial infection was present [16]. These
findings suggest concurrent infections are an important variable in
the differential development of hemorrhagic smallpox over
ordinary smallpox.
Another important difference unique to the animals that
developed hemorrhagic smallpox is sex. Only three female animals
were included in this study and all three developed hemorrhagic-
like smallpox and died. Cell mediated and humoral immune
responses differ among males and females, and in females the
response varies according to menstrual cycle stage [17,18]. Given
that Th2 immune responses predominate during the luteal phase
(including pregnancy) [19,20], and Th1 responses are responsible
for anti-viral immunity [21,22,23], it is possible that sex steroid
hormone-associated effects on the immune system may have
influenced VARV pathogenesis. The historical literature supports
this possibility as it is widely documented that hemorrhagic
smallpox was more common in pregnant women even in the face
of previous variolation or vaccination [24].
Despite having relatively few animals develop hemorrhagic
smallpox, we observed several key differences between the
ordinary and hemorrhagic forms. Most notably, distinct morpho-
logic differences in the lymphoid and hematopoietic responses to
VARV infection were found. In the ordinary model, lymphoid and
myeloid hyperplasias were consistently present, whereas marked
lymphocytolysis and hematopoietic necrosis were found in the
hemorrhagic model. Viral antigen staining patterns also differed.
In the ordinary model, only low level staining was found in what
appear to be marginal zone macrophages and/or dendritic cells on
days 1 and 3 post exposure, coincident with the onset of lymphoid
hyperplasia. Beyond that no viral antigen was found and lymphoid
hyperplasia persisted, suggesting effective viral clearance and an
ongoing active immune response. Similarly, the nodal and splenic
plasmacytosis seen at later time points suggests effective develop-
ment of the adaptive immune response. It is interesting that while
viral antigen staining was found in the spleen (and not the lymph
nodes), significantly more robust and persistent lymphoid
hyperplasia occurred in the lymph nodes, perhaps indicating that
while primary clearance and processing of the blood-borne
antigen occurs in the spleen, trafficking to the nodal lymphocyte
population is important for development of an effective adaptive
response.
In contrast to the ordinary model, viral antigen staining in the
animals that developed hemorrhagic disease was widespread and
involved many tissue types including the lymph nodes and bone
marrow. Within the spleen, antigen staining was not limited to the
marginal zone; periarteriolar lymphoid sheaths and large numbers
of sinusoidal macrophages were also involved. In addition, in both
the spleen and lymph nodes the depleted germinal centers often
contained abundant apoptotic bodies mixed with viral antigen,
suggesting exhaustion of the adaptive response and incomplete
viral clearance. This may explain the consistently higher viral titers
in both blood and tissues, and the more widespread viral antigen
staining seen in these animals. Similar to what has been shown for
other orthopoxvirus infections [25], in both the ordinary and
hemorrhagic forms we confirmed macrophage infection via
positive viral antigen staining and presence of virus ultrastructur-
ally. Thus, it is possible that with an incomplete or ineffective
adaptive response, whether due to high viral load, concurrent
infections, or physiologic state, viral trafficking within macrophag-
es proceeds unchecked. It is also noteworthy that in their review of
human smallpox, Councilman et al describe lymphoid and
hematopoietic necrosis in the hemorrhagic cases only, a finding
which lends validity to the macaque model of hemorrhagic
smallpox [12].
In the hemorrhagic model, expanded distribution of viral
antigen involved not only additional tissue types, but also
additional cell types. Orthopoxviruses are widely known to be
epitheliotropic and we found that to be true in both our ordinary
and hemorrhagic models. Epithelial cells in haired skin and
mucosa were a primary target in both models, and in the
hemorrhagic model, hepatocytes, pneumocytes, adrenocortical
epithelium, and urogenital epithelium were also commonly
involved. Likewise, as discussed above, macrophages were found
to be infected in both models, with more widespread involvement
in the hemorrhagic model. Interestingly, we also found positively
stained pericytes, and to a lesser extent endothelial cells, in tissues
from the animals with hemorrhagic smallpox. In fact, for many of
the additionally affected tissues in the hemorrhagic model,
pericytes were the primary positive cell type. Similar findings
have been reported for cynomolgus macaques experimentally
infected with monkeypox virus [16]. Given the role of pericytes in
maintaining the integrity of small capillaries and post-capillary
venules, it is possible that viral-associated dysfunction of these cell
types may be a primary mechanism by which hemorrhage
develops. Less commonly, endothelial cells were found to be
involved, thus they may also contribute to the loss of vascular wall
integrity. Other possible mechanisms for hemorrhage include
thrombocytopenia and coagulation cascade disorders. Thrombo-
cytopenia did not occur in either model, and coagulation factors
were not evaluated. This is a critical area in need of further
investigation.
We also noted several similarities between the ordinary and
hemorrhagic disease forms. Clinicopathologically, normocytic
normochromic anemia developed in both groups. While hemor-
rhage may have played a role in the animals that developed
hemorrhagic smallpox, this was not the responsible mechanism in
the animals with ordinary smallpox. Other possible mechanisms
include impaired erythrocyte production or hemolysis. The
hematopoietic necrosis observed in the hemorrhagic smallpox
model involved all three cell lineages, including the erythroid
population. However, given the short (2–3 days) disease course, it
is not likely that this played a major role. Hyperbilirubinemia was
not detected in either group, indicating that if hemolysis occurred,
it was not of sufficient magnitude to exceed the capacity of the
liver to remove bilirubin. Additional findings to support or refute a
hemolytic mechanism, such as serum phosphorous concentrations
and erythrocyte cytology were not performed. Another possibility
is ‘anemia of inflammatory disease’ which, despite its alternate
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10 days. In both smallpox models, anemia first developed at day 3,
and in the ordinary model, it persisted through day 11. Thus, this
may be the mechanism responsible for the anemia; however,
further characterization is warranted. Progressive hypoalbumin-
emia was also common to both groups. As with the anemia,
hemorrhage likely played a role in the animals that developed
hemorrhagic smallpox, but not in the ordinary smallpox model.
Renal, intestinal, or hepatic pathology sufficient to result in
protein-losing nephropathy/enteropathy or reduced hepatic
albumin production was not found. In addition, clinical pathology
data supports normal renal and hepatic function. Given that
albumin is a negative acute phase protein, it is likely that acute
inflammation is the primary mechanism responsible for the
reduced serum concentrations in the ordinary smallpox group.
Compared to what is known about human smallpox, our
models resemble the human condition in time to disease onset with
hemorrhagic smallpox with respect to viremia, and gross and
histopathologic appearance of most lesions. Key areas in which
our macaque models differ from the human disease include the
lack of thrombocytopenia in macaques with hemorrhagic
smallpox, and the development of significant lymphadenopathy
in macaques with ordinary smallpox. In humans, thrombocyto-
penia is documented in cases of hemorrhagic smallpox and
lymphadenopathy is not a prominent finding in either form of the
disease. The reason for these differences is not clear. In ordinary
smallpox in humans, Councilman et al describe edema and sinus
histiocytosis as the primary pathologic change in lymph nodes, and
they specifically state that the enlargement is ‘‘due more to edema
than cellular hyperplasia’’ [12]. In contrast, they describe
consistent lymphoid hyperplasia in the spleen [12]. In the
macaque ordinary smallpox model, lymphoid hyperplasia is
minimal in the spleen and marked in the lymph node, with
lymph node edema being only a minor change.
Based on the temporal progression of virologic, pathologic, and
immunologic events after experimental inoculation with variola
virus, our findings suggests that the pathogenesis diverges at the
initial viral clearance stage to produce either the ordinary or
hemorrhagic form of the disease (Figure 7). In both intravenous
inoculation models, viremic blood is filtered through the spleen
and liver. Within 24 hours marginal zone macrophages and
Kupffer cells begin expressing viral antigen indicating likely uptake
and processing of the pathogen. When the immune response is
effective these antigen presenting cells then traffic via the
lymphatics to the lymph nodes where a hyperplastic response
develops. Concurrently, trafficking to other preferred sites such as
skin and gonads occurs, and lesions progress and regress as the
ongoing adaptive immune response controls and clears the
pathogen. In the face of an ineffective immune response,
trafficking via macrophages also occurs. However, lymphoid
necrosis rather than hyperplasia occurs, allowing unabated
trafficking of the virus to other tissues. As in ordinary smallpox,
skin and gonads are targeted, but, in this situation epithelial and
steroidogenic cells in other organs, such liver, lung, kidney, and
adrenal gland are infected. In addition, we see antigen expression
in cells that are not normally regarded as preferred poxviral
targets, such as endothelial cells, pericytes, and hematopoietic
cells. The reason for this additional distribution is not clear. It may
be a reflection of viral load, where the lack of an effective immune
response allows production of large numbers of infectious virions
which then go on to infect the additional cell types. The infected
cells then undergo necrosis, apoptosis, and/or pyroptosis which,
given the widespread state of infection, results in inflammation,
hemorrhage and death.
This study has expanded our knowledge of both the ordinary
and hemorrhagic forms of smallpox, however, many areas warrant
further investigation. As discussed above, determining the
molecular mechanisms responsible for cellular tropism and
effective innate and adaptive immune responses is crucial for
identifying targets of therapeutic intervention. In addition, the
mechanisms of cell death in VARV infection are unclear and
elucidation of these pathways may reveal additional therapeutic
avenues. Further characterization of the reproductive pathology is
also justified. In both males and females, gonads are a primary
target of many orthopoxviruses, and there is a high risk of
spontaneous abortion among pregnant women infected with
variola virus. While direct viral infection of the fetus has been
documented, it is not common, and more often the abortus
presents without pathologic evidence of poxviral infection. Our
IHC findings suggest that viral targeting of thecal cells and
subsequent reduced progesterone production may be one
mechanism by which fetal loss occurs. In addition, historically,
regardless of vaccination or variolation status, pregnant women
were at significantly increased risk for developing fatal infections
when infected with VARV [24]. Given the unique reproductive
physiology of human and non-human Old World primates, the
macaque model may be useful for determining the reasons behind
this enhanced susceptibility. Finally, the appropriateness of any
animal model is based on its resemblance or non-resemblance to
the human condition. In the case of VARV, historical reports
allude to histopathologic variations in the human condition. In
addition to the disparate lymphoid responses discussed above,
Councilman et al also reported that syncytia are common in
human smallpox [12], a salient feature which is lacking in the
macaque models. Given the importance of developing valid and
reliable animal models to satisfy the FDA Animal Efficacy Rule, it
would be wise to apply, to the extent possible, modern techniques
to archived human smallpox tissue in order to have a valid
comparator for development and refinement of animal models.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Animal Care and Use
Committee at the Centers for Disease Control and Prevention,
(Protocol JAHMONC1400). All research involving non-human
primates was performed in accordance with the recommendations
of the Weatherall report, "The use of non-human primates in
research". Animal were anesthetized intramuscularly (im) with
tiletamine-zolazepam (3 mg/kg), and all efforts were made to
minimize suffering.
Animals and virus
Twenty-seven, vaccinia virus-naı ¨ve cynomolgus macaques
(Macaca fascicularis) were anesthetized intramuscularly (im) with
tiletamine-zolazepam (3 mg/kg), and all efforts were made to
minimize suffering. Anesthetized animals were injected intrave-
nously (iv) with either 10
8 (n=18) or 10
9 (n=9) pfu of VARV
Harper strain. The virus seed was prepared as previously
described. Animals were examined at least twice daily post-
exposure and sedated with tiletamine-zolazepam prior to all
phlebotomy and euthanasia procedures. Animals in the 10
8 pfu
group were scheduled for euthanasia and necropsy at days 1, 3, 5,
7, 9 and 11 post infection; animals in the 10
9 pfu group were
scheduled at days 1, 3 and 4. The study design and outcome of
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nonhuman primates (NHPs) infected with VARV was performed
at the Maximum Containment Laboratory, Centers for Disease
Control and Prevention, in Atlanta, Georgia, USA. All animals
were handled in accord with the Guide for the Care and Use of
Laboratory Animals, and the Institutional Animal Care and Use
Committee at the Centers for Disease Control and Prevention.
Enzyme-linked immunosorbent assay (ELISA)
Cytokine/chemokine concentrations in NHP sera/plasma were
assayed using commercially available ELISA kits according to the
manufacturers’ directions. Cytokines/chemokines assayed included
NHP interleukin (IL)-2, IL-4, IL-10, IL-12, interferon (IFN)- c,a n d
tumor necrosis factor (TNF)- a (BioSource International, Inc.,
Camarillo, CA). ELISAs for the detection of human proteins known
Figure 7. Model of VARV pathogenesis. Viremic blood is filtered through the spleen and liver following inoculation. Within 24 hours marginal
zone macrophages and Kupffer cells begin expressing viral antigen indicating likely uptake and processing of the pathogen. When the immune
response is effective these antigen presenting cells then traffic via the lymphatics to the lymph nodes where a hyperplastic response develops.
Concurrently, trafficking to other preferred sites such as skin occurs, and lesions progress and regress as the ongoing adaptive immune response
controls and clears the pathogen. In the face of an ineffective immune response, trafficking via macrophages also occurs, however, lymphoid necrosis
rather than hyperplasia occurs, allowing unabated trafficking of the virus to other tissues. Infected cells undergo necrosis, pyroptosis, and/or
apoptosis which, given the widespread state of infection, results in inflammation, hemorrhage and death.
doi:10.1371/journal.pone.0024832.g007
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IFN-b, macrophage inflammatory protein 1 alpha (MIP-1a), and
MIP-1b (BioSource), and human IL-1b, IL-8, IL-18, and monocyte
chemotactic protein (MCP)-1 (R&D Systems, Minneapolis, MN).
Quantitative real-time PCR
qrt-PCR was performed as previously described [26]. Briefly,
tissues were sectioned into media to generate a 10% homogenate.
The homogenate was subsequently freeze-thawed and sonicated 4
times, centrifuged, and clarified supernatant was removed for
extraction. DNA was extracted from ethylenediaminetetraacetic
acid (EDTA) blood to analyze virus load. All samples were lysed
and extracted using the QIAamp Mini Kit (QIAGEN, Valencia,
CA) according to the manufacturer’s instructions. qrt-PCR was
performed with the LightCycler (Roche Applied Science,
Indianapolis, IN) by use of a pan-Orthopoxvirus assay as described
elsewhere [26] to determine genomes per mg or ml of tissue.
Histopathology and Immunohistochemistry
All NHP postmortem exams were performed on the day of death.
The following tissues were collected at necropsy: normal skin,
mammarygland,skinwithrashand/orpoxlesions,inguinal,axillary,
mandibular, mediastinal, and mesenteric lymph nodes, salivary
gland, testis or ovary, liver, gallbladder, spleen, adrenal gland, left and
right kidneys, lung, heart, tongue, tonsil, larynx, thyroid gland,
parathyroid gland, trachea, esophagus, urinary bladder, prostate
gland or uterus, stomach, pancreas, duodenum, jejunum, ileum,
cecum with ileocecal junction, colon, nares, upper lip, eyes, brain,
pituitary gland, sciatic nerve, skeletal muscle, and femoral bone
marrow. Tissues were fixed in 10% neutral buffered formalin,
embedded in paraffin, sectioned at 5–6 mm, and stained with
hematoxylin & eosin (H&E) according to established protocols [27].
VARV antigen was identified immunohistochemically using
rabbit anti-vaccinia virus polyclonal antibody (1:5000; Antibody
#1069, USAMRIID, Frederick, MD) incubated for 30 minutes at
room temperature (RT). Primary antibody was localized with anti-
rabbit biotinylated secondary antibody (30 minutes at RT),
horseradish peroxidase and diaminobenzidine substrate. Sections
were counterstained with hematoxylin followed by Scott’s tap
water, and examined by light microscopy by board-certified
veterinary pathologists (JAC, AJJ, and JLR). IHC stains were
subjectively scored on a 0–4 scale (0=none; 1=minimal; 2=mild;
3=moderate; 4=marked). For each tissue type, IHC scores for all
3 animals from the same dose and necropsy day group were
summed. If, for an individual animal, more than one slide of the
same tissue type was examined and scored, the average score for
that tissue type was used in the summation.
Electron Microscopy
Skin, inguinal lymph node, liver, spleen, lung, heart, and bone
marrow were analyzed by transmission electron microscopy
(TEM). Tissues were fixed in 2.5% glutaraldehyde in 0.1 M
phosphate buffer (pH 7.3), irradiated (5610
6 rads), and processed
as described [28]. Ultrathin sections were cut, placed on 200-mesh
copper electron microscopy grids, stained with uranyl acetate and
lead citrate. Ultrathin sections were examined at 80 kV on a JOEL
1011 transmission electron microscope.
Supporting Information
Figure S1 10
9 pfu premature death group. Ultrastructural
appearance of immature poxvirus virions within the cytoplasm of a
hemosiderin (*) laden macrophage, TEM; 10000X; mag
bar=2 um.
(TIF)
Figure S2 10
9 pfu premature death group. Ultrastructural
appearance of immature poxvirus virions (thick arrow) within the
cytoplasm of a both an apoptotic granulocyte and an adjacent
lysed cell (thin arrow), TEM; 12000X; mag bar=2 um.
(TIF)
Figure S3 Hemogram findings in the 10
8 pfu (blue) and
10
9 pfu (red) dose groups. Gray areas indicate the normal
reference range. Error bars indicate standard error of the mean
(SEM).
(TIF)
Figure S4 Clinical chemistry findings in the 10
8 pfu
(blue) and 10
9 pfu (red) dose groups. Gray areas indicate the
normal reference range.
(TIF)
Figure S5 Mean tissue genome concentrations in the 10
8
pfu group.
(TIF)
Figure S6 Mean tissue genome concentrations in the 10
9
pfu dose group.
(TIF)
Table S1 Study Design.
(DOCX)
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